期刊
AMERICAN JOURNAL OF CLINICAL PATHOLOGY
卷 149, 期 2, 页码 117-127出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/AJCP/AQX132
关键词
Forkhead box O3A protein (FoxO3A); Hepatocellular carcinoma; Immunohistochemistry; Prognosis
类别
资金
- National Research Foundation of Korea (NRF) - Korean - government (MSIP) [2015R1C1A1A01056091]
- National Research Foundation of Korea [2015R1C1A1A01056091] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
Objectives: Recent research has demonstrated that forkhead box O3a (FoxO3a) may function as an oncogenic transcription factor. We sought to validate the clinicopathologic significance of FoxO3a expression in hepatocellular carcinoma (HCC). Methods: Western blotting and immunohistochemistry were used to determine FoxO3a expression. In vitro cell proliferation and migration assays were performed in a HepG2 cell line. Results: FoxO3a was overexpressed in 121 (64.71%) cases of HCC. FoxO3a overexpression was associated with aggressive phenotypes of HCC, such as histologic grade (P < .001), stage (P = .031), and small vessel invasion (P < .001). FoxO3a overexpression was also correlated with poor disease-free survival in both univariate and multivariate survival analyses (P = .001 and P = .018, respectively). Downregulation of FoxO3a in a HepG2 cell line inhibited cell proliferation and migration. Conclusions: These results suggest a role for FoxO3a in HCC progression and support the potential use as a prognostic biomarker.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据